1-7 of 7
LAWRENCE SCHWARTZ
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dynamic Changes in Lymph Node Size and Skin Scoring Predict Response to Treatment in CTCL: An Interim Analysis

Lauren M. Fahmy, Hye Ryung Yang, Mengxi Zhou, Volkan Beylergil, Celine M. Schreidah, Zaid Bilgrami, Bradley D. Kwinta, Lawrence Schwartz, Antonio T. Fojo, Susan E. Bates, Larisa J. Geskin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4443.
https://doi.org/10.1182/blood-2023-189493
Published: 2023
Journal Articles

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Clinical Trials & Observations
Elise A. Olsen, Sean Whittaker, Rein Willemze, Lauren Pinter-Brown, Francine Foss, Larisa Geskin, Lawrence Schwartz, Steven Horwitz, Joan Guitart, John Zic, Youn H. Kim, Gary S. Wood, Madeleine Duvic, Wei Ai, Michael Girardi, Alejandro Gru, Emmanuella Guenova, Emmilia Hodak, Richard Hoppe, Werner Kempf, Ellen Kim, Mary Jo Lechowicz, Pablo Ortiz-Romero, Evangelia Papadavid, Pietro Quaglino, Mark Pittelkow, H. Miles Prince, Jose Antonio Sanches, Makoto Sugaya, Maarten Vermeer, Jasmine Zain, Robert Knobler, Rudolf Stadler, Martine Bagot, Julia Scarisbrick
Journal: Blood
Blood (2022) 140 (5): 419–437.
https://doi.org/10.1182/blood.2021012057
Published: 2022
Journal Articles

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Clinical Trials & Observations
Jennifer E. Amengual, Renee Lichtenstein, Jennifer Lue, Ahmed Sawas, Changchun Deng, Emily Lichtenstein, Karen Khan, Laine Atkins, Aishling Rada, Hye A. Kim, Codruta Chiuzan, Matko Kalac, Enrica Marchi, Lorenzo Falchi, Mark A. Francescone, Lawrence Schwartz, Serge Cremers, Owen A. O’Connor
Journal: Blood
Blood (2018) 131 (4): 397–407.
https://doi.org/10.1182/blood-2017-09-806737
Published: 2018
Includes: Supplemental data
Journal Articles

Interim FDG PET Imaging in CALGB 50203 Trial of Stage I/II Non-Bulky Hodgkin Lymphoma: Would Using Combined PET and CT Criteria Better Predict Response Than Each Test Alone?,

Lale Kostakoglu, MD, MPH, Heiko Schoder, MD, Nathan Hall, MD, PhD, David J. Straus, MD, Jeffrey L Johnson, PhD, Lawrence Schwartz, MD, Ann LaCasce, MD, Sin-Ho Jung, PhD, Nancy L. Bartlett, MD, George P. Canellos, MD, Bruce D. Cheson, MD
Journal: Blood
Blood (2011) 118 (21): 3644.
https://doi.org/10.1182/blood.V118.21.3644.3644
Published: 2011
Journal Articles

Efficacy and Safety of Secondary Prophylactic Versus On-Demand Sucrose-Formulated Recombinant Factor VIII Treatment in Adults with Severe Hemophilia A: Results from a 13-Month Crossover Study

Peter Collins, Albert Faradji, Massimo Morfini, Monika Maas Enriquez, MD, Eduard Gorina, MD, Lawrence Schwartz, Georg Lemm, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 516.
https://doi.org/10.1182/blood.V112.11.516.516
Published: 2008
Journal Articles

Doxorubicin, Vinblastine and Gemcitabine (AVG), a Novel Regimen Excluding Bleomycin for the Treatment of Early Stage Hodgkin Lymphoma (HL): Results of CALGB 50203.

David Straus, MD, Ann LaCase, MD, Malik Juweid, MD, Lale Kostakogolu, MD, Nathan Hall, MD, Jeffery Johnson, MS, Sin-Ho Jung, Ph.D., George Canellos, MD, Lawrence Schwartz, MD, Bruce Cheson, MD
Journal: Blood
Blood (2007) 110 (11): 214.
https://doi.org/10.1182/blood.V110.11.214.214
Published: 2007
Journal Articles

The Combined Study of Agglutination, Hemolysis and Erythrophagocytosis : With Special Reference to Acquired Hemolytic Anemia

JAMES A. BONNIN, LAWRENCE SCHWARTZ
Journal: Blood
Blood (1954) 9 (8): 773–788.
https://doi.org/10.1182/blood.V9.8.773.773
Published: 1954